↓ Skip to main content

A Specific CD44lo CD25lo Subpopulation of Regulatory T Cells Inhibits Anti-Leukemic Immune Response and Promotes the Progression in a Mouse Model of Chronic Lymphocytic Leukemia

Overview of attention for article published in Frontiers in immunology, February 2022
Altmetric Badge

About this Attention Score

  • Average Attention Score compared to outputs of the same age
  • Average Attention Score compared to outputs of the same age and source

Mentioned by

twitter
2 X users

Citations

dimensions_citation
4 Dimensions

Readers on

mendeley
10 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
A Specific CD44lo CD25lo Subpopulation of Regulatory T Cells Inhibits Anti-Leukemic Immune Response and Promotes the Progression in a Mouse Model of Chronic Lymphocytic Leukemia
Published in
Frontiers in immunology, February 2022
DOI 10.3389/fimmu.2022.781364
Pubmed ID
Authors

Agnieszka Goral, Malgorzata Firczuk, Klaudyna Fidyt, Marta Sledz, Francesca Simoncello, Karolina Siudakowska, Giulia Pagano, Etienne Moussay, Jérôme Paggetti, Patrycja Nowakowska, Stefania Gobessi, Joanna Barankiewicz, Aleksander Salomon-Perzynski, Federica Benvenuti, Dimitar G. Efremov, Przemyslaw Juszczynski, Ewa Lech-Maranda, Angelika Muchowicz

X Demographics

X Demographics

The data shown below were collected from the profiles of 2 X users who shared this research output. Click here to find out more about how the information was compiled.
As of 1 July 2024, you may notice a temporary increase in the numbers of X profiles with Unknown location. Click here to learn more.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 10 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 10 100%

Demographic breakdown

Readers by professional status Count As %
Unspecified 1 10%
Other 1 10%
Lecturer 1 10%
Student > Doctoral Student 1 10%
Student > Master 1 10%
Other 2 20%
Unknown 3 30%
Readers by discipline Count As %
Unspecified 1 10%
Pharmacology, Toxicology and Pharmaceutical Science 1 10%
Biochemistry, Genetics and Molecular Biology 1 10%
Agricultural and Biological Sciences 1 10%
Immunology and Microbiology 1 10%
Other 0 0%
Unknown 5 50%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 2. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 18 March 2022.
All research outputs
#17,285,374
of 26,166,431 outputs
Outputs from Frontiers in immunology
#18,959
of 33,003 outputs
Outputs of similar age
#260,073
of 455,844 outputs
Outputs of similar age from Frontiers in immunology
#936
of 1,690 outputs
Altmetric has tracked 26,166,431 research outputs across all sources so far. This one is in the 31st percentile – i.e., 31% of other outputs scored the same or lower than it.
So far Altmetric has tracked 33,003 research outputs from this source. They typically receive more attention than average, with a mean Attention Score of 8.5. This one is in the 36th percentile – i.e., 36% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 455,844 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 39th percentile – i.e., 39% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 1,690 others from the same source and published within six weeks on either side of this one. This one is in the 38th percentile – i.e., 38% of its contemporaries scored the same or lower than it.